Management of Low RDW with High NRBC

Diagnostic Evaluation

• The American College of Physicians recommends a complete blood count with MCV, hemoglobin, and reticulocyte count to characterize the anemia pattern, as suggested by the Journal of Clinical Oncology 3
• The low RDW (≤14.0%) suggests homogeneous red cell population, which may indicate thalassemia trait, anemia of chronic disease, or early stages of critical illness rather than iron deficiency, according to MMWR Recommendations and Reports 1
• Peripheral blood smear is essential to assess for schistocytes, hemolysis, and red cell morphology, as recommended by the Journal of Clinical Oncology 3
• Serum ferritin, transferrin saturation, and CRP should be measured to differentiate iron deficiency from chronic disease, as suggested by Praxis Medical Insights 2, 4

Management Algorithm

• The Journal of Clinical Oncology recommends considering hematology consultation for unexplained or refractory cases 3
• If anemia is present, do not empirically treat with iron based solely on anemia, as low RDW makes iron deficiency less likely, according to Praxis Medical Insights 2, 4
• If ferritin confirms iron deficiency, initiate iron supplementation and investigate gastrointestinal blood loss, as recommended by Praxis Medical Insights 4
• If thalassemia is suspected, confirm with hemoglobin electrophoresis and avoid iron unless concurrent deficiency documented, according to Praxis Medical Insights 4

Hemolysis Management

• The Journal of Clinical Oncology recommends following immune-related adverse event protocols if applicable, including permanent discontinuation of immune checkpoint inhibitors, hematology consultation, and corticosteroids 1-2 mg/kg/day for grade 3-4 hemolysis 3
• Consider RBC transfusion per existing guidelines, targeting hemoglobin 7-8 g/dL in stable patients, as suggested by the Journal of Clinical Oncology 3
• Supplement with folic acid 1 mg daily, as recommended by the Journal of Clinical Oncology 3